nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCB1—Levothyroxine—hypothyroidism	0.0829	0.28	CbGbCtD
Daunorubicin—ABCB1—Liothyronine—hypothyroidism	0.0829	0.28	CbGbCtD
Daunorubicin—ABCB1—Liotrix—hypothyroidism	0.0809	0.273	CbGbCtD
Daunorubicin—NR5A1—corpus luteum—hypothyroidism	0.0548	0.188	CbGeAlD
Daunorubicin—CYP3A4—Levothyroxine—hypothyroidism	0.0497	0.168	CbGbCtD
Daunorubicin—NR5A1—seminiferous tubule of testis—hypothyroidism	0.0465	0.159	CbGeAlD
Daunorubicin—NR5A1—Nuclear Receptors—THRA—hypothyroidism	0.00954	0.145	CbGpPWpGaD
Daunorubicin—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00848	0.0245	CcSEcCtD
Daunorubicin—NR5A1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00754	0.114	CbGpPWpGaD
Daunorubicin—Angina pectoris—Liothyronine—hypothyroidism	0.00648	0.0187	CcSEcCtD
Daunorubicin—NR5A1—Nuclear Receptors—THRB—hypothyroidism	0.00615	0.0931	CbGpPWpGaD
Daunorubicin—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00585	0.0169	CcSEcCtD
Daunorubicin—Myocardial infarction—Liothyronine—hypothyroidism	0.00581	0.0168	CcSEcCtD
Daunorubicin—Necrosis—Liotrix—hypothyroidism	0.00488	0.0141	CcSEcCtD
Daunorubicin—NR5A1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00486	0.0736	CbGpPWpGaD
Daunorubicin—Arrhythmia—Liothyronine—hypothyroidism	0.00476	0.0137	CcSEcCtD
Daunorubicin—NR5A1—adrenal cortex—hypothyroidism	0.00475	0.0163	CbGeAlD
Daunorubicin—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00454	0.0131	CcSEcCtD
Daunorubicin—Hyperkinesia—Levothyroxine—hypothyroidism	0.00454	0.0131	CcSEcCtD
Daunorubicin—Extravasation—Liotrix—hypothyroidism	0.00439	0.0127	CcSEcCtD
Daunorubicin—Cellulitis—Liotrix—hypothyroidism	0.00421	0.0122	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00417	0.012	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00417	0.012	CcSEcCtD
Daunorubicin—Ulcer—Liotrix—hypothyroidism	0.00405	0.0117	CcSEcCtD
Daunorubicin—CYP1A2—urine—hypothyroidism	0.00403	0.0138	CbGeAlD
Daunorubicin—Increased appetite—Levothyroxine—hypothyroidism	0.00402	0.0116	CcSEcCtD
Daunorubicin—Increased appetite—Dextrothyroxine—hypothyroidism	0.00402	0.0116	CcSEcCtD
Daunorubicin—Hypertension—Liothyronine—hypothyroidism	0.004	0.0116	CcSEcCtD
Daunorubicin—NR5A1—gonad—hypothyroidism	0.00394	0.0135	CbGeAlD
Daunorubicin—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00387	0.0112	CcSEcCtD
Daunorubicin—Cardiac failure—Levothyroxine—hypothyroidism	0.00387	0.0112	CcSEcCtD
Daunorubicin—NR5A1—pituitary gland—hypothyroidism	0.00384	0.0132	CbGeAlD
Daunorubicin—Affect lability—Dextrothyroxine—hypothyroidism	0.00372	0.0108	CcSEcCtD
Daunorubicin—Affect lability—Levothyroxine—hypothyroidism	0.00372	0.0108	CcSEcCtD
Daunorubicin—Tachycardia—Liothyronine—hypothyroidism	0.00369	0.0107	CcSEcCtD
Daunorubicin—Cardiac arrest—Levothyroxine—hypothyroidism	0.00359	0.0104	CcSEcCtD
Daunorubicin—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00359	0.0104	CcSEcCtD
Daunorubicin—Mood swings—Levothyroxine—hypothyroidism	0.00358	0.0103	CcSEcCtD
Daunorubicin—Mood swings—Dextrothyroxine—hypothyroidism	0.00358	0.0103	CcSEcCtD
Daunorubicin—Dehydration—Dextrothyroxine—hypothyroidism	0.00351	0.0102	CcSEcCtD
Daunorubicin—Dehydration—Levothyroxine—hypothyroidism	0.00351	0.0102	CcSEcCtD
Daunorubicin—NR5A1—adrenal gland—hypothyroidism	0.00343	0.0118	CbGeAlD
Daunorubicin—Hyperkinesia—Liotrix—hypothyroidism	0.00334	0.00965	CcSEcCtD
Daunorubicin—Dysphagia—Levothyroxine—hypothyroidism	0.00327	0.00944	CcSEcCtD
Daunorubicin—Dysphagia—Dextrothyroxine—hypothyroidism	0.00327	0.00944	CcSEcCtD
Daunorubicin—NR5A1—female gonad—hypothyroidism	0.0032	0.011	CbGeAlD
Daunorubicin—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00318	0.0092	CcSEcCtD
Daunorubicin—Angina pectoris—Levothyroxine—hypothyroidism	0.00318	0.0092	CcSEcCtD
Daunorubicin—Sweating increased—Levothyroxine—hypothyroidism	0.00318	0.0092	CcSEcCtD
Daunorubicin—Sweating increased—Dextrothyroxine—hypothyroidism	0.00318	0.0092	CcSEcCtD
Daunorubicin—YWHAG—adrenal cortex—hypothyroidism	0.00314	0.0108	CbGeAlD
Daunorubicin—Cardiac failure congestive—Liotrix—hypothyroidism	0.00307	0.00886	CcSEcCtD
Daunorubicin—ABCC6—cardiovascular system—hypothyroidism	0.00304	0.0104	CbGeAlD
Daunorubicin—YWHAG—heart—hypothyroidism	0.00304	0.0104	CbGeAlD
Daunorubicin—TOP2B—adrenal cortex—hypothyroidism	0.00303	0.0104	CbGeAlD
Daunorubicin—Body temperature increased—Liothyronine—hypothyroidism	0.00299	0.00864	CcSEcCtD
Daunorubicin—Increased appetite—Liotrix—hypothyroidism	0.00296	0.00855	CcSEcCtD
Daunorubicin—TOP2B—heart—hypothyroidism	0.00293	0.01	CbGeAlD
Daunorubicin—Renal impairment—Liotrix—hypothyroidism	0.00292	0.00844	CcSEcCtD
Daunorubicin—CYP3A4—urine—hypothyroidism	0.00292	0.01	CbGeAlD
Daunorubicin—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00287	0.0083	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00287	0.0083	CcSEcCtD
Daunorubicin—YWHAG—cardiovascular system—hypothyroidism	0.00286	0.00983	CbGeAlD
Daunorubicin—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00285	0.00825	CcSEcCtD
Daunorubicin—Myocardial infarction—Levothyroxine—hypothyroidism	0.00285	0.00825	CcSEcCtD
Daunorubicin—Cardiac failure—Liotrix—hypothyroidism	0.00285	0.00823	CcSEcCtD
Daunorubicin—NR5A1—testis—hypothyroidism	0.00284	0.00973	CbGeAlD
Daunorubicin—TOP2B—cardiovascular system—hypothyroidism	0.00276	0.00947	CbGeAlD
Daunorubicin—Affect lability—Liotrix—hypothyroidism	0.00274	0.00791	CcSEcCtD
Daunorubicin—Cardiac arrest—Liotrix—hypothyroidism	0.00264	0.00764	CcSEcCtD
Daunorubicin—Mood swings—Liotrix—hypothyroidism	0.00263	0.00761	CcSEcCtD
Daunorubicin—NR5A1—cerebellum—hypothyroidism	0.00262	0.00898	CbGeAlD
Daunorubicin—YWHAG—gonad—hypothyroidism	0.0026	0.00892	CbGeAlD
Daunorubicin—Dehydration—Liotrix—hypothyroidism	0.00258	0.00747	CcSEcCtD
Daunorubicin—YWHAG—pituitary gland—hypothyroidism	0.00254	0.0087	CbGeAlD
Daunorubicin—TOP2B—gonad—hypothyroidism	0.00251	0.00859	CbGeAlD
Daunorubicin—TOP2B—pituitary gland—hypothyroidism	0.00244	0.00838	CbGeAlD
Daunorubicin—Flushing—Dextrothyroxine—hypothyroidism	0.00243	0.00701	CcSEcCtD
Daunorubicin—Flushing—Levothyroxine—hypothyroidism	0.00243	0.00701	CcSEcCtD
Daunorubicin—ABCC6—blood—hypothyroidism	0.00241	0.00825	CbGeAlD
Daunorubicin—Dysphagia—Liotrix—hypothyroidism	0.0024	0.00694	CcSEcCtD
Daunorubicin—POR—adrenal cortex—hypothyroidism	0.00239	0.00819	CbGeAlD
Daunorubicin—Angina pectoris—Liotrix—hypothyroidism	0.00234	0.00676	CcSEcCtD
Daunorubicin—Sweating increased—Liotrix—hypothyroidism	0.00234	0.00676	CcSEcCtD
Daunorubicin—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00234	0.00675	CcSEcCtD
Daunorubicin—Arrhythmia—Levothyroxine—hypothyroidism	0.00234	0.00675	CcSEcCtD
Daunorubicin—ABCC6—thyroid gland—hypothyroidism	0.00232	0.00797	CbGeAlD
Daunorubicin—Alopecia—Dextrothyroxine—hypothyroidism	0.00231	0.00668	CcSEcCtD
Daunorubicin—Alopecia—Levothyroxine—hypothyroidism	0.00231	0.00668	CcSEcCtD
Daunorubicin—POR—heart—hypothyroidism	0.00231	0.00792	CbGeAlD
Daunorubicin—YWHAG—adrenal gland—hypothyroidism	0.00227	0.00777	CbGeAlD
Daunorubicin—YWHAG—blood—hypothyroidism	0.00227	0.00777	CbGeAlD
Daunorubicin—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00221	0.0335	CbGpPWpGaD
Daunorubicin—YWHAG—thyroid gland—hypothyroidism	0.00219	0.0075	CbGeAlD
Daunorubicin—TOP2B—adrenal gland—hypothyroidism	0.00218	0.00749	CbGeAlD
Daunorubicin—TOP2B—blood—hypothyroidism	0.00218	0.00749	CbGeAlD
Daunorubicin—Tremor—Dextrothyroxine—hypothyroidism	0.00213	0.00616	CcSEcCtD
Daunorubicin—Tremor—Levothyroxine—hypothyroidism	0.00213	0.00616	CcSEcCtD
Daunorubicin—YWHAG—female gonad—hypothyroidism	0.00211	0.00725	CbGeAlD
Daunorubicin—Acute coronary syndrome—Liotrix—hypothyroidism	0.00211	0.0061	CcSEcCtD
Daunorubicin—TOP2B—thyroid gland—hypothyroidism	0.00211	0.00723	CbGeAlD
Daunorubicin—Renal failure—Liotrix—hypothyroidism	0.00211	0.00609	CcSEcCtD
Daunorubicin—Myocardial infarction—Liotrix—hypothyroidism	0.0021	0.00607	CcSEcCtD
Daunorubicin—Agitation—Levothyroxine—hypothyroidism	0.00209	0.00605	CcSEcCtD
Daunorubicin—Agitation—Dextrothyroxine—hypothyroidism	0.00209	0.00605	CcSEcCtD
Daunorubicin—TOP2B—female gonad—hypothyroidism	0.00204	0.00698	CbGeAlD
Daunorubicin—NR5A1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00202	0.0306	CbGpPWpGaD
Daunorubicin—Palpitations—Levothyroxine—hypothyroidism	0.00201	0.00581	CcSEcCtD
Daunorubicin—Palpitations—Dextrothyroxine—hypothyroidism	0.00201	0.00581	CcSEcCtD
Daunorubicin—Convulsion—Levothyroxine—hypothyroidism	0.00197	0.0057	CcSEcCtD
Daunorubicin—Convulsion—Dextrothyroxine—hypothyroidism	0.00197	0.0057	CcSEcCtD
Daunorubicin—Arthralgia—Levothyroxine—hypothyroidism	0.00194	0.0056	CcSEcCtD
Daunorubicin—Arthralgia—Dextrothyroxine—hypothyroidism	0.00194	0.0056	CcSEcCtD
Daunorubicin—Anxiety—Dextrothyroxine—hypothyroidism	0.00193	0.00558	CcSEcCtD
Daunorubicin—Anxiety—Levothyroxine—hypothyroidism	0.00193	0.00558	CcSEcCtD
Daunorubicin—POR—pituitary gland—hypothyroidism	0.00193	0.00661	CbGeAlD
Daunorubicin—ABCC10—adrenal cortex—hypothyroidism	0.00189	0.0065	CbGeAlD
Daunorubicin—ABCC6—liver—hypothyroidism	0.00188	0.00645	CbGeAlD
Daunorubicin—YWHAG—testis—hypothyroidism	0.00187	0.00643	CbGeAlD
Daunorubicin—Confusional state—Dextrothyroxine—hypothyroidism	0.00187	0.00541	CcSEcCtD
Daunorubicin—Confusional state—Levothyroxine—hypothyroidism	0.00187	0.00541	CcSEcCtD
Daunorubicin—ABCC10—heart—hypothyroidism	0.00183	0.00628	CbGeAlD
Daunorubicin—Shock—Levothyroxine—hypothyroidism	0.00183	0.00528	CcSEcCtD
Daunorubicin—Shock—Dextrothyroxine—hypothyroidism	0.00183	0.00528	CcSEcCtD
Daunorubicin—Tachycardia—Dextrothyroxine—hypothyroidism	0.00181	0.00524	CcSEcCtD
Daunorubicin—Tachycardia—Levothyroxine—hypothyroidism	0.00181	0.00524	CcSEcCtD
Daunorubicin—TOP2B—testis—hypothyroidism	0.00181	0.00619	CbGeAlD
Daunorubicin—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.0018	0.00519	CcSEcCtD
Daunorubicin—Hyperhidrosis—Levothyroxine—hypothyroidism	0.0018	0.00519	CcSEcCtD
Daunorubicin—ABCB11—testis—hypothyroidism	0.00179	0.00612	CbGeAlD
Daunorubicin—Flushing—Liotrix—hypothyroidism	0.00178	0.00516	CcSEcCtD
Daunorubicin—YWHAG—liver—hypothyroidism	0.00177	0.00608	CbGeAlD
Daunorubicin—YWHAG—cerebellum—hypothyroidism	0.00173	0.00594	CbGeAlD
Daunorubicin—XDH—liver—hypothyroidism	0.00173	0.00593	CbGeAlD
Daunorubicin—POR—adrenal gland—hypothyroidism	0.00172	0.00591	CbGeAlD
Daunorubicin—POR—blood—hypothyroidism	0.00172	0.00591	CbGeAlD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00172	0.0261	CbGpPWpGaD
Daunorubicin—Arrhythmia—Liotrix—hypothyroidism	0.00172	0.00497	CcSEcCtD
Daunorubicin—TOP2B—liver—hypothyroidism	0.00171	0.00586	CbGeAlD
Daunorubicin—Alopecia—Liotrix—hypothyroidism	0.0017	0.00491	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00169	0.00489	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00169	0.00489	CcSEcCtD
Daunorubicin—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00169	0.0256	CbGpPWpGaD
Daunorubicin—ABCB11—liver—hypothyroidism	0.00169	0.00579	CbGeAlD
Daunorubicin—Insomnia—Levothyroxine—hypothyroidism	0.00168	0.00486	CcSEcCtD
Daunorubicin—Insomnia—Dextrothyroxine—hypothyroidism	0.00168	0.00486	CcSEcCtD
Daunorubicin—TOP2B—cerebellum—hypothyroidism	0.00167	0.00572	CbGeAlD
Daunorubicin—POR—thyroid gland—hypothyroidism	0.00166	0.0057	CbGeAlD
Daunorubicin—Dyspnoea—Levothyroxine—hypothyroidism	0.00166	0.00479	CcSEcCtD
Daunorubicin—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00166	0.00479	CcSEcCtD
Daunorubicin—Dysgeusia—Liotrix—hypothyroidism	0.00164	0.00474	CcSEcCtD
Daunorubicin—POR—female gonad—hypothyroidism	0.00161	0.00551	CbGeAlD
Daunorubicin—TOP2A—adrenal gland—hypothyroidism	0.00161	0.00551	CbGeAlD
Daunorubicin—TOP2A—blood—hypothyroidism	0.00161	0.00551	CbGeAlD
Daunorubicin—Fatigue—Dextrothyroxine—hypothyroidism	0.0016	0.00463	CcSEcCtD
Daunorubicin—Fatigue—Levothyroxine—hypothyroidism	0.0016	0.00463	CcSEcCtD
Daunorubicin—ABCC10—gonad—hypothyroidism	0.00157	0.00538	CbGeAlD
Daunorubicin—Tremor—Liotrix—hypothyroidism	0.00157	0.00453	CcSEcCtD
Daunorubicin—TOP2A—thyroid gland—hypothyroidism	0.00155	0.00531	CbGeAlD
Daunorubicin—Agitation—Liotrix—hypothyroidism	0.00154	0.00445	CcSEcCtD
Daunorubicin—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00153	0.00442	CcSEcCtD
Daunorubicin—Feeling abnormal—Levothyroxine—hypothyroidism	0.00153	0.00442	CcSEcCtD
Daunorubicin—ABCC10—pituitary gland—hypothyroidism	0.00153	0.00525	CbGeAlD
Daunorubicin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00152	0.00439	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00152	0.00439	CcSEcCtD
Daunorubicin—Syncope—Liotrix—hypothyroidism	0.0015	0.00434	CcSEcCtD
Daunorubicin—TOP2A—female gonad—hypothyroidism	0.0015	0.00514	CbGeAlD
Daunorubicin—Palpitations—Liotrix—hypothyroidism	0.00148	0.00428	CcSEcCtD
Daunorubicin—Urticaria—Dextrothyroxine—hypothyroidism	0.00148	0.00427	CcSEcCtD
Daunorubicin—Urticaria—Levothyroxine—hypothyroidism	0.00148	0.00427	CcSEcCtD
Daunorubicin—Loss of consciousness—Liotrix—hypothyroidism	0.00147	0.00425	CcSEcCtD
Daunorubicin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00147	0.00424	CcSEcCtD
Daunorubicin—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00147	0.00424	CcSEcCtD
Daunorubicin—Abdominal pain—Levothyroxine—hypothyroidism	0.00147	0.00424	CcSEcCtD
Daunorubicin—Body temperature increased—Levothyroxine—hypothyroidism	0.00147	0.00424	CcSEcCtD
Daunorubicin—Convulsion—Liotrix—hypothyroidism	0.00145	0.00419	CcSEcCtD
Daunorubicin—Hypertension—Liotrix—hypothyroidism	0.00145	0.00418	CcSEcCtD
Daunorubicin—CYP1B1—heart—hypothyroidism	0.00144	0.00494	CbGeAlD
Daunorubicin—Arthralgia—Liotrix—hypothyroidism	0.00143	0.00412	CcSEcCtD
Daunorubicin—Chest pain—Liotrix—hypothyroidism	0.00143	0.00412	CcSEcCtD
Daunorubicin—POR—testis—hypothyroidism	0.00142	0.00489	CbGeAlD
Daunorubicin—Anxiety—Liotrix—hypothyroidism	0.00142	0.00411	CcSEcCtD
Daunorubicin—Confusional state—Liotrix—hypothyroidism	0.00138	0.00398	CcSEcCtD
Daunorubicin—ABCC10—adrenal gland—hypothyroidism	0.00137	0.00469	CbGeAlD
Daunorubicin—ABCC10—blood—hypothyroidism	0.00137	0.00469	CbGeAlD
Daunorubicin—Oedema—Liotrix—hypothyroidism	0.00137	0.00395	CcSEcCtD
Daunorubicin—Anaphylactic shock—Liotrix—hypothyroidism	0.00137	0.00395	CcSEcCtD
Daunorubicin—CYP1B1—cardiovascular system—hypothyroidism	0.00136	0.00466	CbGeAlD
Daunorubicin—Infection—Liotrix—hypothyroidism	0.00136	0.00392	CcSEcCtD
Daunorubicin—POR—liver—hypothyroidism	0.00135	0.00462	CbGeAlD
Daunorubicin—Shock—Liotrix—hypothyroidism	0.00134	0.00389	CcSEcCtD
Daunorubicin—ABCC1—adrenal cortex—hypothyroidism	0.00134	0.00459	CbGeAlD
Daunorubicin—Tachycardia—Liotrix—hypothyroidism	0.00133	0.00385	CcSEcCtD
Daunorubicin—Asthenia—Levothyroxine—hypothyroidism	0.00133	0.00385	CcSEcCtD
Daunorubicin—Asthenia—Dextrothyroxine—hypothyroidism	0.00133	0.00385	CcSEcCtD
Daunorubicin—TOP2A—testis—hypothyroidism	0.00133	0.00455	CbGeAlD
Daunorubicin—Hyperhidrosis—Liotrix—hypothyroidism	0.00132	0.00382	CcSEcCtD
Daunorubicin—ABCC10—thyroid gland—hypothyroidism	0.00132	0.00452	CbGeAlD
Daunorubicin—POR—cerebellum—hypothyroidism	0.00132	0.00451	CbGeAlD
Daunorubicin—Pruritus—Levothyroxine—hypothyroidism	0.00131	0.0038	CcSEcCtD
Daunorubicin—Pruritus—Dextrothyroxine—hypothyroidism	0.00131	0.0038	CcSEcCtD
Daunorubicin—NR5A1—Generic Transcription Pathway—THRA—hypothyroidism	0.0013	0.0197	CbGpPWpGaD
Daunorubicin—Anorexia—Liotrix—hypothyroidism	0.0013	0.00376	CcSEcCtD
Daunorubicin—ABCC1—heart—hypothyroidism	0.0013	0.00444	CbGeAlD
Daunorubicin—ABCC10—female gonad—hypothyroidism	0.00127	0.00437	CbGeAlD
Daunorubicin—Diarrhoea—Levothyroxine—hypothyroidism	0.00127	0.00367	CcSEcCtD
Daunorubicin—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00127	0.00367	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00124	0.0036	CcSEcCtD
Daunorubicin—Insomnia—Liotrix—hypothyroidism	0.00124	0.00357	CcSEcCtD
Daunorubicin—CYP1B1—gonad—hypothyroidism	0.00123	0.00423	CbGeAlD
Daunorubicin—Dyspnoea—Liotrix—hypothyroidism	0.00122	0.00352	CcSEcCtD
Daunorubicin—CYP1B1—pituitary gland—hypothyroidism	0.0012	0.00413	CbGeAlD
Daunorubicin—Decreased appetite—Liotrix—hypothyroidism	0.00119	0.00343	CcSEcCtD
Daunorubicin—Vomiting—Levothyroxine—hypothyroidism	0.00118	0.00341	CcSEcCtD
Daunorubicin—Vomiting—Dextrothyroxine—hypothyroidism	0.00118	0.00341	CcSEcCtD
Daunorubicin—Fatigue—Liotrix—hypothyroidism	0.00118	0.0034	CcSEcCtD
Daunorubicin—Rash—Dextrothyroxine—hypothyroidism	0.00117	0.00339	CcSEcCtD
Daunorubicin—Rash—Levothyroxine—hypothyroidism	0.00117	0.00339	CcSEcCtD
Daunorubicin—Dermatitis—Levothyroxine—hypothyroidism	0.00117	0.00338	CcSEcCtD
Daunorubicin—Dermatitis—Dextrothyroxine—hypothyroidism	0.00117	0.00338	CcSEcCtD
Daunorubicin—Constipation—Liotrix—hypothyroidism	0.00117	0.00338	CcSEcCtD
Daunorubicin—Headache—Levothyroxine—hypothyroidism	0.00116	0.00336	CcSEcCtD
Daunorubicin—Headache—Dextrothyroxine—hypothyroidism	0.00116	0.00336	CcSEcCtD
Daunorubicin—ABCC10—testis—hypothyroidism	0.00113	0.00388	CbGeAlD
Daunorubicin—Feeling abnormal—Liotrix—hypothyroidism	0.00113	0.00325	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Liotrix—hypothyroidism	0.00112	0.00323	CcSEcCtD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00111	0.0168	CbGpPWpGaD
Daunorubicin—ABCG2—adrenal cortex—hypothyroidism	0.00111	0.0038	CbGeAlD
Daunorubicin—Nausea—Levothyroxine—hypothyroidism	0.0011	0.00319	CcSEcCtD
Daunorubicin—Nausea—Dextrothyroxine—hypothyroidism	0.0011	0.00319	CcSEcCtD
Daunorubicin—ABCC2—adrenal gland—hypothyroidism	0.0011	0.00376	CbGeAlD
Daunorubicin—ABCC2—blood—hypothyroidism	0.0011	0.00376	CbGeAlD
Daunorubicin—Urticaria—Liotrix—hypothyroidism	0.00109	0.00314	CcSEcCtD
Daunorubicin—ABCC1—pituitary gland—hypothyroidism	0.00108	0.00371	CbGeAlD
Daunorubicin—Abdominal pain—Liotrix—hypothyroidism	0.00108	0.00312	CcSEcCtD
Daunorubicin—Body temperature increased—Liotrix—hypothyroidism	0.00108	0.00312	CcSEcCtD
Daunorubicin—CYP1B1—adrenal gland—hypothyroidism	0.00108	0.00369	CbGeAlD
Daunorubicin—CYP1B1—blood—hypothyroidism	0.00107	0.00369	CbGeAlD
Daunorubicin—ABCG2—heart—hypothyroidism	0.00107	0.00368	CbGeAlD
Daunorubicin—ABCC10—liver—hypothyroidism	0.00107	0.00367	CbGeAlD
Daunorubicin—ABCC10—cerebellum—hypothyroidism	0.00104	0.00358	CbGeAlD
Daunorubicin—CYP1B1—thyroid gland—hypothyroidism	0.00104	0.00356	CbGeAlD
Daunorubicin—CYP1A1—heart—hypothyroidism	0.00102	0.00349	CbGeAlD
Daunorubicin—Hypersensitivity—Liotrix—hypothyroidism	0.00101	0.00291	CcSEcCtD
Daunorubicin—CYP1B1—female gonad—hypothyroidism	0.001	0.00344	CbGeAlD
Daunorubicin—Asthenia—Liotrix—hypothyroidism	0.00098	0.00283	CcSEcCtD
Daunorubicin—NR5A1—Gene Expression—ZNF764—hypothyroidism	0.000973	0.0147	CbGpPWpGaD
Daunorubicin—ABCC1—adrenal gland—hypothyroidism	0.000967	0.00332	CbGeAlD
Daunorubicin—ABCC1—blood—hypothyroidism	0.000967	0.00332	CbGeAlD
Daunorubicin—Pruritus—Liotrix—hypothyroidism	0.000967	0.00279	CcSEcCtD
Daunorubicin—Diarrhoea—Liotrix—hypothyroidism	0.000935	0.0027	CcSEcCtD
Daunorubicin—ABCC1—thyroid gland—hypothyroidism	0.000933	0.0032	CbGeAlD
Daunorubicin—NR5A1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000928	0.0141	CbGpPWpGaD
Daunorubicin—ABCC2—testis—hypothyroidism	0.000908	0.00311	CbGeAlD
Daunorubicin—Dizziness—Liotrix—hypothyroidism	0.000903	0.00261	CcSEcCtD
Daunorubicin—ABCC1—female gonad—hypothyroidism	0.000902	0.00309	CbGeAlD
Daunorubicin—ABCG2—pituitary gland—hypothyroidism	0.000896	0.00307	CbGeAlD
Daunorubicin—CYP1B1—testis—hypothyroidism	0.000889	0.00305	CbGeAlD
Daunorubicin—Vomiting—Liotrix—hypothyroidism	0.000869	0.00251	CcSEcCtD
Daunorubicin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000866	0.0131	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000865	0.0131	CbGpPWpGaD
Daunorubicin—Rash—Liotrix—hypothyroidism	0.000861	0.00249	CcSEcCtD
Daunorubicin—Dermatitis—Liotrix—hypothyroidism	0.000861	0.00249	CcSEcCtD
Daunorubicin—ABCC2—liver—hypothyroidism	0.000858	0.00294	CbGeAlD
Daunorubicin—Headache—Liotrix—hypothyroidism	0.000856	0.00247	CcSEcCtD
Daunorubicin—CYP1B1—liver—hypothyroidism	0.000841	0.00288	CbGeAlD
Daunorubicin—NR5A1—Generic Transcription Pathway—THRB—hypothyroidism	0.000839	0.0127	CbGpPWpGaD
Daunorubicin—YWHAG—Membrane Trafficking—CLTC—hypothyroidism	0.000831	0.0126	CbGpPWpGaD
Daunorubicin—CYP1B1—cerebellum—hypothyroidism	0.000821	0.00282	CbGeAlD
Daunorubicin—Nausea—Liotrix—hypothyroidism	0.000811	0.00235	CcSEcCtD
Daunorubicin—ABCG2—adrenal gland—hypothyroidism	0.000801	0.00275	CbGeAlD
Daunorubicin—ABCG2—blood—hypothyroidism	0.0008	0.00274	CbGeAlD
Daunorubicin—ABCC1—testis—hypothyroidism	0.0008	0.00274	CbGeAlD
Daunorubicin—ABCG2—thyroid gland—hypothyroidism	0.000772	0.00265	CbGeAlD
Daunorubicin—CYP1A2—blood—hypothyroidism	0.00077	0.00264	CbGeAlD
Daunorubicin—CYP1A1—blood—hypothyroidism	0.00076	0.00261	CbGeAlD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000756	0.0115	CbGpPWpGaD
Daunorubicin—ABCC1—liver—hypothyroidism	0.000756	0.00259	CbGeAlD
Daunorubicin—ABCG2—female gonad—hypothyroidism	0.000746	0.00256	CbGeAlD
Daunorubicin—CYP1A2—thyroid gland—hypothyroidism	0.000743	0.00255	CbGeAlD
Daunorubicin—CYP3A5—blood—hypothyroidism	0.000743	0.00255	CbGeAlD
Daunorubicin—ABCC1—cerebellum—hypothyroidism	0.000739	0.00253	CbGeAlD
Daunorubicin—CYP1A1—thyroid gland—hypothyroidism	0.000733	0.00252	CbGeAlD
Daunorubicin—ABCC2—NRF2 pathway—SLC5A7—hypothyroidism	0.000725	0.011	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000717	0.0109	CbGpPWpGaD
Daunorubicin—CYP1A1—female gonad—hypothyroidism	0.000709	0.00243	CbGeAlD
Daunorubicin—CYP3A5—female gonad—hypothyroidism	0.000693	0.00238	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—CLTC—hypothyroidism	0.000693	0.0105	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000664	0.0101	CbGpPWpGaD
Daunorubicin—ABCG2—testis—hypothyroidism	0.000662	0.00227	CbGeAlD
Daunorubicin—CYP1B1—Endogenous sterols—POMC—hypothyroidism	0.000636	0.00963	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—THRA—hypothyroidism	0.000627	0.0095	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000627	0.00949	CbGpPWpGaD
Daunorubicin—ABCG2—liver—hypothyroidism	0.000626	0.00215	CbGeAlD
Daunorubicin—ABCG2—cerebellum—hypothyroidism	0.000611	0.0021	CbGeAlD
Daunorubicin—CYP1A2—liver—hypothyroidism	0.000602	0.00207	CbGeAlD
Daunorubicin—CYP1A1—liver—hypothyroidism	0.000594	0.00204	CbGeAlD
Daunorubicin—CYP3A5—liver—hypothyroidism	0.000581	0.00199	CbGeAlD
Daunorubicin—YWHAG—Membrane Trafficking—PIK3C2A—hypothyroidism	0.000571	0.00865	CbGpPWpGaD
Daunorubicin—CYP3A4—blood—hypothyroidism	0.000558	0.00191	CbGeAlD
Daunorubicin—ABCB1—adrenal cortex—hypothyroidism	0.000547	0.00188	CbGeAlD
Daunorubicin—ABCB1—heart—hypothyroidism	0.000529	0.00181	CbGeAlD
Daunorubicin—ABCB1—cardiovascular system—hypothyroidism	0.000499	0.00171	CbGeAlD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000485	0.00735	CbGpPWpGaD
Daunorubicin—ABCB1—gonad—hypothyroidism	0.000453	0.00155	CbGeAlD
Daunorubicin—NR5A1—Gene Expression—NKX2-5—hypothyroidism	0.000447	0.00677	CbGpPWpGaD
Daunorubicin—ABCB1—pituitary gland—hypothyroidism	0.000442	0.00152	CbGeAlD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000442	0.00669	CbGpPWpGaD
Daunorubicin—CYP3A4—liver—hypothyroidism	0.000436	0.0015	CbGeAlD
Daunorubicin—NR5A1—Gene Expression—THRB—hypothyroidism	0.000404	0.00612	CbGpPWpGaD
Daunorubicin—ABCB1—adrenal gland—hypothyroidism	0.000395	0.00135	CbGeAlD
Daunorubicin—ABCB1—blood—hypothyroidism	0.000395	0.00135	CbGeAlD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000393	0.00596	CbGpPWpGaD
Daunorubicin—ABCB1—thyroid gland—hypothyroidism	0.000381	0.00131	CbGeAlD
Daunorubicin—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.000372	0.00563	CbGpPWpGaD
Daunorubicin—ABCB1—female gonad—hypothyroidism	0.000368	0.00126	CbGeAlD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000346	0.00524	CbGpPWpGaD
Daunorubicin—ABCB1—testis—hypothyroidism	0.000326	0.00112	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—VAV3—hypothyroidism	0.000326	0.00495	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000326	0.00494	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000313	0.00474	CbGpPWpGaD
Daunorubicin—ABCB1—liver—hypothyroidism	0.000309	0.00106	CbGeAlD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000302	0.00458	CbGpPWpGaD
Daunorubicin—ABCB1—cerebellum—hypothyroidism	0.000301	0.00103	CbGeAlD
Daunorubicin—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000295	0.00447	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	0.00029	0.00439	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—IYD—hypothyroidism	0.00028	0.00424	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000272	0.00413	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—AVP—hypothyroidism	0.000252	0.00382	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.00024	0.00363	CbGpPWpGaD
Daunorubicin—CYP1B1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000239	0.00363	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ATP5O—hypothyroidism	0.000238	0.00361	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000238	0.00361	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000232	0.00352	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00023	0.00348	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—TPO—hypothyroidism	0.000224	0.00339	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—IYD—hypothyroidism	0.000206	0.00313	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000202	0.00306	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.0002	0.00303	CbGpPWpGaD
Daunorubicin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000192	0.00292	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000192	0.00292	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00019	0.00288	CbGpPWpGaD
Daunorubicin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000182	0.00275	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ATP5O—hypothyroidism	0.000176	0.00266	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000168	0.00255	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000167	0.00254	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000166	0.00251	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TPO—hypothyroidism	0.000165	0.0025	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000157	0.00238	CbGpPWpGaD
Daunorubicin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000156	0.00236	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—IYD—hypothyroidism	0.000155	0.00235	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000153	0.00232	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—IYD—hypothyroidism	0.00015	0.00227	CbGpPWpGaD
Daunorubicin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000147	0.00223	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—IYD—hypothyroidism	0.000136	0.00207	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—IYD—hypothyroidism	0.000135	0.00205	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ATP5O—hypothyroidism	0.000132	0.002	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ATP5O—hypothyroidism	0.000128	0.00193	CbGpPWpGaD
Daunorubicin—CYP1B1—Biological oxidations—POMC—hypothyroidism	0.000127	0.00193	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TPO—hypothyroidism	0.000124	0.00188	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000124	0.00188	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TPO—hypothyroidism	0.00012	0.00182	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ATP5O—hypothyroidism	0.000116	0.00176	CbGpPWpGaD
Daunorubicin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000116	0.00176	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000115	0.00174	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.000115	0.00174	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000111	0.00168	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000109	0.00165	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TPO—hypothyroidism	0.000109	0.00165	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TPO—hypothyroidism	0.000108	0.00164	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—TSHB—hypothyroidism	0.000104	0.00157	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—IYD—hypothyroidism	9.78e-05	0.00148	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.4e-05	0.00142	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.28e-05	0.00141	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—IYD—hypothyroidism	9.24e-05	0.0014	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3C2A—hypothyroidism	9.24e-05	0.0014	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.17e-05	0.00139	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.05e-05	0.00137	CbGpPWpGaD
Daunorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.95e-05	0.00136	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ATP5O—hypothyroidism	8.31e-05	0.00126	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—POMC—hypothyroidism	8.29e-05	0.00126	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.07e-05	0.00122	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.99e-05	0.00121	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ATP5O—hypothyroidism	7.85e-05	0.00119	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—POMC—hypothyroidism	7.83e-05	0.00119	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TPO—hypothyroidism	7.82e-05	0.00118	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—SLC5A5—hypothyroidism	7.76e-05	0.00118	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TSHB—hypothyroidism	7.64e-05	0.00116	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TPO—hypothyroidism	7.39e-05	0.00112	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—IYD—hypothyroidism	7.38e-05	0.00112	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	7.31e-05	0.00111	CbGpPWpGaD
Daunorubicin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.25e-05	0.0011	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—AVP—hypothyroidism	7.22e-05	0.00109	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.84e-05	0.00104	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3C2A—hypothyroidism	6.81e-05	0.00103	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.72e-05	0.00102	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.36e-05	0.000963	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.29e-05	0.000953	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ATP5O—hypothyroidism	6.27e-05	0.00095	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TPO—hypothyroidism	5.9e-05	0.000894	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—IYD—hypothyroidism	5.89e-05	0.000892	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TSHB—hypothyroidism	5.74e-05	0.00087	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SLC5A5—hypothyroidism	5.72e-05	0.000867	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TSHB—hypothyroidism	5.55e-05	0.000841	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	5.53e-05	0.000838	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3C2A—hypothyroidism	5.12e-05	0.000775	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TSHB—hypothyroidism	5.05e-05	0.000765	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.05e-05	0.000765	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ATP5O—hypothyroidism	5.01e-05	0.000759	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TSHB—hypothyroidism	5e-05	0.000757	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—POMC—hypothyroidism	4.99e-05	0.000756	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3C2A—hypothyroidism	4.95e-05	0.00075	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.88e-05	0.00074	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TPO—hypothyroidism	4.71e-05	0.000713	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—IYD—hypothyroidism	4.55e-05	0.000689	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PRL—hypothyroidism	4.53e-05	0.000687	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3C2A—hypothyroidism	4.5e-05	0.000682	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	4.46e-05	0.000675	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.36e-05	0.000661	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.36e-05	0.000661	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC5A5—hypothyroidism	4.3e-05	0.000651	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC5A5—hypothyroidism	4.16e-05	0.00063	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—POMC—hypothyroidism	4.06e-05	0.000615	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ATP5O—hypothyroidism	3.87e-05	0.000586	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—POMC—hypothyroidism	3.85e-05	0.000584	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC5A5—hypothyroidism	3.78e-05	0.000573	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC5A5—hypothyroidism	3.74e-05	0.000567	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TPO—hypothyroidism	3.63e-05	0.000551	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TSHB—hypothyroidism	3.62e-05	0.000548	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.44e-05	0.000521	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TSHB—hypothyroidism	3.42e-05	0.000518	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	3.23e-05	0.000489	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	3.05e-05	0.000462	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.01e-05	0.000456	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—POMC—hypothyroidism	2.99e-05	0.000453	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TSHB—hypothyroidism	2.73e-05	0.000414	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC5A5—hypothyroidism	2.71e-05	0.00041	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC5A5—hypothyroidism	2.56e-05	0.000388	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.43e-05	0.000369	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—POMC—hypothyroidism	2.25e-05	0.000341	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TSHB—hypothyroidism	2.18e-05	0.00033	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—POMC—hypothyroidism	2.17e-05	0.000329	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.04e-05	0.00031	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—POMC—hypothyroidism	1.98e-05	0.0003	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—POMC—hypothyroidism	1.96e-05	0.000297	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.94e-05	0.000294	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.92e-05	0.00029	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TSHB—hypothyroidism	1.68e-05	0.000255	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.63e-05	0.000247	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.5e-05	0.000227	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—POMC—hypothyroidism	1.42e-05	0.000215	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—POMC—hypothyroidism	1.34e-05	0.000203	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.26e-05	0.000191	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—POMC—hypothyroidism	1.07e-05	0.000162	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—POMC—hypothyroidism	8.54e-06	0.000129	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—POMC—hypothyroidism	6.59e-06	9.98e-05	CbGpPWpGaD
